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NeuronAbstract Ischemic stroke and ischemia/reperfusion (I/R) injury induced by thrombolytic therapy are
conditions with high mortality and serious long-term physical and cognitive disabilities. They have a
major impact on global public health. These disorders are associated with multiple insults to the cerebral
microcirculation, including reactive oxygen species (ROS) overproduction, leukocyte adhesion and
inﬁltration, brain blood barrier (BBB) disruption, and capillary hypoperfusion, ultimately resulting in
tissue edema, hemorrhage, brain injury and delayed neuron damage. Traditional Chinese medicine (TCM)
has been used in China, Korea, Japan and other Asian countries for treatment of a wide range of diseases.
In China, the usage of compound TCM preparation to treat cerebrovascular diseases dates back to the Han
Dynasty. Even thousands of years earlier, the medical formulary recorded many classical prescriptions for
treating cerebral I/R-related diseases. This review summarizes current information and underlying
mechanisms regarding the ameliorating effects of compound TCM preparation, Chinese materia medica,
and active components on I/R-induced cerebral microcirculatory disturbances, brain injury and neuron
damage.
& 2015 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical
Sciences. Production and hosting by Elsevier B.V. Open access under CC BY-NC-ND license. 1. Introduction
Stroke is the second leading cause of mortality in the world, resulting
in 6,671,000 deaths (11.9% of all deaths) in 20121. Pathogenically,
ischemic stroke caused by vessel occlusions accounts for 85% of all
conditions. Since the core of brain tissue undergoes necrotic cell
death within a few minutes of the onset of cerebral ischemia, early
restoration of blood ﬂow by thrombolytic therapy decreases morbidity
and mortality in these patients2. Paradoxically, reperfusion itself
evokes additional injury to ischemic penumbra, a region bordering
the infarct core, causing the so-called ischemia-reperfusion (I/R)
injury. Such injury exacerbates brain damage, leading to increases in
severe morbidity in surviving victims. I/R imposes multiple insults to
the cerebral microcirculation, including reactive oxygen species
(ROS) outburst, inﬂammatory mediator overproduction, leukocyte
inﬁltration, microvessel hyperpermeabilty, brain blood barrier (BBB)
disruption, capillary hypoperfusion, etc. Many of these factors are
thought to play signiﬁcant roles in the pathogenesis of post-ischemic
injury in stroke patients3. Much effort has been made to attenuate the
microcirculatory disturbances by ablating a single factor in the
pathogenesis, including introduction of recombinant tissue plasmino-
gen activator (rtPA)4,5, antioxidants6, anti-intercellular adhesion
molecule-1 (ICAM-1) antibody7, calcium-stabilizing agents8 and
anti-excitotoxic agents9. However, clinical trials have failed to show
positive effects in patients with ischemic stroke. Other therapeutic
approaches, such as anti-inﬂammatory10 and anti-apoptotic11 agents,
are being evaluated, but no successful clinical trials have thus far been
reported. These results suggest that such microcirculatory distur-
bances are part of a complicated pathological process involving
multiple, coordinated events. Once initiated, the process may only be
interrupted by a remedy consisting of multiple compositions that
target the underlying insults.
For more than two thousand years, traditional Chinese medicine
(TCM) has been used in China, Korea, Japan and other Asian
countries for the clinical treatment of cerebrovascular diseases
including stroke, encephalitis, dizziness, insomnia, amnesia, and
dementia. In China, the use of compound TCM preparations to
treat cerebrovascular diseases dates back to the Han Dynasty.
“Treatise on Cold Damage (Shang Han Lun)” and “Synopsis of
the Golden Chamber (Jin Kui Yao Lue)” appeared at that timewhich recorded several classical formulas, including Chaihu Jia
Longgu Muli Tang, Guizhi Fuling Wan, Gualou Guizhi Tang, and
others, which were devoted to cope with cerebrovascular diseases.
In the Tang dynasty, medical formulas were further developed, as
shown by “Important Prescriptions Worth a Thousand Gold for
Emergency (Qian Jin Fang)” and “Arcane Essentials from the
Imperial Library (Wai Tai Mi Yao)”; these documented the use of
Xiaoxuming Tang, Dihuang Yinzi and Huanglian Jiedu Tang for
the treatment of cerebrovascular diseases.
In the dynasties that followed, more compound TCM prepara-
tions were used in clinic. In the Song dynasty, treatments included
Sijunzi Tang and Longdan Xiegan Tang, documented from
“Formulary of the Bureau Taiping People's Welfare Pharmacy
(Tai Ping Hui Min He Ji Ju Fang)”. In the Yuan dynasty,
medicines included Shengmai San, as reported in “Revelation of
Medicine (Yi Xue Qi Yuan)”. In the Jin dynasty, the use of Chaihu
Shugan San was mentioned in “Jing-Yue's Collected Works (Jing
Yue Quan Shu)”. Finally, in the Qing dynasty, Buyang Huanwu
Tang and Taohong Siwu Tang were used according to “Correction
on Errors in Medical Works (Yi Lin Gai Cuo)” and “Golden
Mirror of the Medical Ancestors (Yi Zong Jin Jian)”, respectively.
Nowadays in China, several new compound TCM preparations
have been formulated for the treatment of cerebrovascular dis-
eases. Based on classical formulas and approved by the State Food
and Drug Administration (SFDA), these include Cerebralcare
Granules (Yangxue Qingnao granule), Tongxinluo capsule,
Shenfu injection, Danhong injection, Huatuo Zaizao extractum.
The name, composition and origin of the compound TCM
preparations that are derived from TCM literatures or approved
by the SFDA and cited in the present review are listed in Table 1.
In addition, Chinese materia medica as well as active ingredients
and components included in compound TCM preparations are
listed in Table 2. These represent substances of recent research
interest as related to their possible roles in the pathogenesis of
I/R-induced brain injury, neuron damage and the underlying
mechanisms. The present review is based on 139 references
published from 1995 to 2014, mainly focusing on the ameliorating
effects and underlying mechanisms of TCM preparations, Chinese
materia medica, and active compounds on I/R-induced cerebral
microcirculatory disturbances, brain and neuron damage.
Table 1 The name, composition and origin of compound TCM preparations.
Compound TCM
preparation
Composition Origin
Buyang Huanwu
decoction
Huangqi (Radix Astragali seu Hedysari), Danggui (Radix Angelicae Sinensis),
Chishao (Radix Paeoniae Rubra), Dilong (Lumbricus), Chuanxiong (Rhizoma
Ligustici Chuanxiong), Honghua (Flos Carthami), Taoren (Semen Persicae)
“Correction on Errors in Medical
Works” (Qing dynasty)
Chaihu Jia Longgu
Muli Tang
Chaihu (Radix Bupleuri), Longgu (Os Draconis), Huangqin (Radix Scutellariae),
Shengjiang (Rhizoma Zingiberis), Qiandan (Minium), Renshen (Radix Ginseng),
Guizhi (Ramulus Cinnamomi), Fuling (Poria), Banxia (Rhizoma Pinelliae),
Dahuang (Radix et Rhizoma Rhei), Muli (Concha Ostreae), Dazao (Fructus
Jujubae)
“Treatise on Cold Damage”
(Han dynasty)
Danhong injection Danshen (Radix Salviae Miltiorrhizae), Honghua (Flos Carthami) Approved by SFDA
(Z20026866)
Dihuang Yinzi Shengdihuang (Radix Rehmanniae Recens), Lugen (Rhizoma Phragmitis),
Maidong (Radix Ophiopogonis), Renshen (Radix Ginseng), Baimi (Mel), Chenpi
(Pericarpium Citri Reticulatae), Shengjiang (Rhizoma Zingiberis)
“Arcane Essentials from the
Imperial Library” (Tang
dynasty)
Fufang Danggui injection Danggui (Radix Angelicae Sinensis), Chuanxiong (Rhizoma Ligustici
Chuanxiong), Honghua (Flos Carthami)
Approved by SFDA
(Z42021410)
Gualou Guizhi Tang Gualou (Fructus Trichosanthis), Guizhi (Ramulus Cinnamomi), Baishao (Radix
Paeoniae Alba), Gancao (Radix Glycyrrhizae), Shengjiang (Rhizoma Zingiberis),
Dazao (Fructus Jujubae)
“Synopsis of the Golden
Chamber”
(Han dynasty)
Guizhi Fuling Wan Guizhi (Ramulus Cinnamomi), Fuling (Poria), Gancao (Radix Glycyrrhizae),
Mudanpi (Cortex Moutan Radicis), Chishao (Radix Paeoniae Rubra), Taoren
(Semen Persicae)
“Synopsis of the Golden
Chamber”
(Han dynasty)
Huatuo Zaizao extractum Danggui (Radix Angelicae Sinensis), Chuanxiong (Rhizoma Ligustici
Chuanxiong), Bingpian (Bomeolum Syntheticum), Baishao (Radix Paeoniae
Alba), Renshen (Radix Ginseng), Wuweizi (Fructus Schisandrae Chinensis),
Maqianzi (Semen Strychni), Honghua (Flos Carthami), Tiannanxing (Rhizoma
Arisaematis)
Approved by SFDA
(Z44020748)
Huanshaodan decoction Shudihuang (Radix Rehmanniae Preparata), Shanzhuyu (Fructus Corni), Shanyao
(Rhizoma Dioscoreae), Gouqizi (Fructus Lycii), Duzhong (Cortex Eucommiae),
Bajitian (Radix Morindae Ofﬁcinalis), Roucongrong (Herba Cistanches),
Wuweizi (Fructus Schisandrae Chinensis), Xiaohuixiang (Fructus Foeniculi),
Chushizi (Fructus Broussonetiae), Niuxi (Radix Cyathulae), Fuling (Poria)
Approved by SFDA
(Z50020189)
Huanglian Jiedu Tang Huangqin (Radix Scutellariae), Huanglian (Rhizoma Coptidis), Huangbai (Cortex
Phellodendri), Zhizi (Fructus Gardenia)
“Arcane Essentials from the
Imperial Library” (Tang
dynasty)
Naoshuantong capsule Puhuang (Pollen Typhae), Chishao (Radix Paeoniae Rubra), Yujin (Radix
Curcumae), Tianma (Rhizoma Gastrodiae), Loulu (Radix Rhapontici)
Approved by SFDA
(Z20040093)
Shenfu injection Renshen (Radix Ginseng), Fuzi (Radix Aconiti Lateralis Preparata) Approved by SFDA
(Z51020664)
Shenqi Fuzheng injection Dangshen (Radix Codonopsis), Huangqi (Radix Astragali seu Hedysari) Approved by SFDA
(Z19990065)
Shengmai San Renshen (Radix Ginseng), Maidong (Radix Ophiopogonis), Wuweizi (Fructus
Schisandrae Chinensis)
“Revelation of Medicine” (Jin
dynasty)
Taohong Siwu Tang Shudihuang (Radix Rehmanniae Preparata), Danggui (Radix Angelicae
Sinensis), Baishao (Radix Paeoniae Alba), Chuanxiong (Rhizoma Ligustici
Chuanxiong), Taoren (Semen Persicae), Honghua (Flos Carthami)
“Golden Mirror of the Medical
Ancestors” (Qing dynasty)
Tianma Gouteng granule Tianma (Rhizoma Gastrodiae), Gouteng (Ramulus Uncariae cum Uncis),
Shijueming (Concha Haliotidis), Zhizi (Fructus Gardeniae), Huangqin (Radix
Scutellariae), Niuxi (Radix Cyathulae), Duzhong (Cortex Eucommiae),Yimucao
(Herba Leonuri), Sangjisheng (Herba Taxilli), Shouwuteng (Caulis Polygoni
Multiﬂori), Fuling (Poria)
Approved by SFDA
(Z51021084)
Tongxinluo capsule Renshen (Radix Ginseng), Shuizhi (Hirudo), Quanxie (Scorpio), Chishao (Radix
Paeoniae Rubra), Chantui (Periostracum Cicadae), Tubiechong (Eupolyphaga
seu Steleophaga), Wugong (Scolopendra), Tanxiang (Lignum Santali Albi),
Jiangxiang (Lignum Dalbergiae Odoriferae), Ruxiang (Olibanum), Suanzaoren
(Semen Ziziphi Spinosae), Bingpian (Bomeolum Syntheticum)
Approved by SFDA
(Z19980015)
Xiaoxuming decoction Mahuang (Herba Ephedrae), Guizhi (Ramulus Cinnamomi), Fangfeng (Radix
Saposhnikoviae), Fangji (Radix Stephaniae Tetrandrae), Xingren (Semen
Armeniacae Amarum), Huangqin (Radix Scutellariae), Renshen (Radix
Ginseng), Gancao (Radix Glycyrrhizae), Dazao (Fructus Jujubae), Chuanxiong
(Rhizoma Ligustici Chuanxiong), Baishao (Radix Paeoniae Alba), Fuzi (Radix
Aconiti Lateralis Preparata), Shengjiang (Rhizoma Zingiberis)
“Important Prescriptions Worth a
Thousand Gold for Emergency”
(Tang dynasty)
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Table 1 (continued )
Compound TCM
preparation
Composition Origin
Xingnaojing injection Shexiang (Moschus), Yujin (Radix Curcumae), Bingpian (Bomeolum
Syntheticum), Zhizi (Fructus Gardeniae)
Approved by SFDA
(Z53021638)
Cerebralcare Granules
(Yangxue Qingnao
granule)
Danggui (Radix Angelicae Sinensis), Chuanxiong (Rhizoma Ligustici
Chuanxiong), Baishao (Radix Paeoniae Alba), Shudihuang (Radix Rehmanniae
Preparata), Gouteng (Ramulus Uncariae cum Uncis), Jixueteng (Caulis
Spatholobi), Xiakucao (Spica Prunellae), Juemingzi (Semen Cassiae),
Zhenzhumu (Concha Margaritifera), Yanhusuo (Rhizoma Corydalis), Xixin
(Herba Asari)
Approved by SFDA
(Z10960082)
Table 2 The structures and sources of active components of Chinese materia medica.
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active compounds on pathogenesis of cerebral microcirculatory
disturbances induced by I/R
2.1. Oxidative stress
Signiﬁcant amounts of ROS are generated during cerebral I/R, which
are widely regarded as the initial step in brain damage after stroke.
Numerous clinical and experimental observations have shown
increased ROS formation during all forms of stroke injury. ROS are
highly active and able to react with DNA, protein, and lipid directly,
causing damage and dysfunction of the molecules to various degree48.
The primary source of ROS during I/R injury is the mitochondria,
which produce superoxide anion radicals during the electron transport
process. Other potentially important sources of ROS include xanthine
oxidase, cyclooxygenase, lipooxygenase, and others, depending on cell
types. Oxygen free radicals can also be generated by activated
microglia and inﬁltrating leukocytes via the nicotinamide adenine
dinucleotide phosphate (NADPH) oxidase pathway following reperfu-
sion49. In recent studies, researchers found that some compound TCM
preparations, Chinese materia medica and active components produce
positive effects on cerebrovascular diseases partially due to their
antioxidant properties. Using dihydrorhodamine 123 (DHR), a hydro-
gen peroxide-sensitive mitochondrial probe, researchers demonstrated
in vivo that compound TCM preparations, such as Cerebralcare
Granules attenuates DHR ﬂuorescence intensity in gerbil cerebral
microvessels, in either the early phase (60 min) or late phase (5 days)
of reperfusion after global ischemia50,51. The single active component
notoginsenoside R1 was found to prevent oxidative stress by suppres-
sing both mitochondrial and NADPH oxidase-dependent superoxide
generation and inhibiting production of malondialdehyde (MDA),
protein carbonyl, and 8-hydroxydeoxyguanosine (8-OHdG) in rat with
middle cerebral artery occlusion (MCAO) and reperfusion in vivo34.
This compound also had antioxidant activity in primary cortical
neurons stimulated by oxygen-glucose deprivation (OGD) followed
by reoxygenation in vitro34. Other compound TCM preparations, such
as Yiqi Tongluo Jiedu capsule52, as well as several active components
from Chinese materia medica (including total glycoside from Chishao,
Radix Paeoniae Rubra53, astragaloside13,14, and tetrahydroxystilbene
glucoside46) alleviated ROS production in cerebral tissue via inhibiting
inducible nitric oxide synthase (iNOS) activation and nitric oxide (NO)
overproduction. Other experiments reported that Chinese materia
medica Danshen (Radix Salviae Miltiorrhizae)54 and active component
baicalin19 exert their antioxidant effect by lowering adenosine meta-
bolites hypoxanthine and inhibiting cyclooxygenase, respectively. In
addition to ROS source regulation, TCM preparation, Chinese materia
medica and active compounds ameliorate I/R-induced oxidative stress
by scavenging free radicals directly or by modulating tissue anti-
oxidant potency. In a recently published study, three classical formulas
(Huanglian Jiedu Tang, Chaihu Jia Longgu Muli Tang, and Guizhi
Fuling Wan) showed scavenging activity for free-radical superoxide
anion radicals, hydroxyl radicals and 1,1-diphenyl-2-picrylhydrazyl
radical 2,2-diphenyl-1-(2,4,6-trinitrophenyl) hydrazyl (DPPH), respec-
tively, while suppressing lipid peroxidation55. Another study reported
that the single active component salvianolic acid A reduces the MDA
contents in the cortex, hippocampus and corpus striatum in I/R rat
brain, which may also attribute to its scavenging effect on free
hydroxyl radicals in vitro38. Shengmai San, another classical formula,
improved oxidative damage manifested as suppression of MDA and
thiobarbituric acid reactive substance (TBARS) formation and
increased superoxide dismutase (SOD) and glutathione peroxidase(GSH-Px) activities in brain tissues from rodent global or MCAO
models. This treatment was active whether given before ischemia or
after re-perfusion56–58. In parallel, aqueous or ethanolic extract from
Baihuasuantengguo (Embelia ribes Burm) increased the glutathione
(GSH), GSH-Px, glutathione reductase and glutathione-S-transferase
levels in both hippocampus and frontal cortex with decreases in lactate
dehydrogenase (LDH) level in serum and TBARS levels in hippo-
campus and frontal cortex in rat after MCAO59,60. Lavender oil was
also found to reduce the levels of mitochondria-generated ROS, MDA
and carbonyl, and to upregulate the ratio of GSH/glutathione disulﬁde
(GSSG), the activities of SOD, catalase (CAT) and GSH-Px in brain
tissue after focal ischemia61. Similar antioxidant effects have been
reported for some other TCM preparation, such as Tongxinluo
capsule62, Yimucao (Herba Leonuri) injection63, and active compo-
nents, such as Yinxing (Folium Ginkgo) extract64, paeonol35 and 30-
methoxy-puerarin12.2.2. Inﬂammatory mediators
Inﬂammation is increasingly recognized to be the key element in the
pathological progression of ischemic stroke, as early inﬂammatory
responses may potentiate reperfusion injury in post-ischemic brain
tissue. There are several resident cell populations within brain tissue
that are able to secrete proinﬂammatory mediators after an ischemic
insult, including endothelial cells, leukocytes, astrocytes, microglia and
neurons. Activation of transcription factors via nuclear factor κ-B (NF-
κB), mitogen activated protein kinase (MAPK), and activator protein-1
(AP-1) inﬂammatory signaling pathway causes an increased production
of cytokines, chemokines, adhesion molecules and other proinﬂamma-
tory mediators65. Several agents that can regulate inﬂammatory
mediators or transcription factors reduce infarct size and neurological
deﬁcits following focal stroke in rodents; such treatments are
considered to be an alternative therapeutic approach in stroke
patients66. In this regard, Guizhi Fuling capsules, a classical formula,
were reported to down-regulate the expression of pro-inﬂammatory
cytokines [including interleukin-1β (IL-1β) and tissue necrosis factor-α
(TNF-α)] and markedly up-regulate the expression of anti-
inﬂammatory cytokines interleukin-10 (IL-10) and IL-10 receptor at
both mRNA and protein levels in rats with focal cerebral I/R. The
serum levels of these inﬂammatory cytokines were regulated in the
same way67. In other in vivo MCAO experiments, TCM Naomaitong
preparation68 and the single active component tetrandrine47 have
proven to decrease the expression and mRNA level of TNF-α, vascular
adhesion molecule-1 (VCAM-1), ICAM-1 in brain tissue 1 or 3 days
after reperfusion, partly due to suppressing NF-κB activation. Similar
results were found for TCM preparations, such as Taohong Siwu
Tang69, FBD formula [a herbal formula composed of Fuling (Poria),
Baizhu (Rhizoma Atractylodis Macrocephalae) and Danggui (Radix
Angelicae Sinensis)]70, as well as Chinese materia medica Danshen
(Radix Salviae miltiorrhizae) aqueous extract71. A broad spectrum of
cytokines and chemokines were abrogated by treatment with these
TCM, including high-sensitivity C-reactive protein (hs-CRP), hypoxia-
inducible factor (HIF)-1α, IL-1β, interleukin-8 (IL-8), TNF-α, iNOS
levels in serum or brain, and TNF-α mRNA and transforming growth
factor β1 (TGF-β1) expression in cerebral tissue; these effects were
partly due to down-regulation of cerebral Inhibitory-κB-α (I-κBα) and
NF-κB phosphrylation70. In a global cerebral ischemia model, treatment
with the single active component resveratrol before insult reduced
astroglial and microglial activation as well as cyclooxygenase-2
(COX-2) and iNOS expression 7 days after I/R. These effects
Kai Sun et al.14were attributed to suppression of NF-κB and Jun N-terminal kinase
(JNK) activation36. In addition to in vivo results, in vitro experi-
ments demonstrated that another active component honokiol
reduced TNF-α and NO level in the primary cultured microglia
medium and in the microglia and astrocytes co-culture medium.
Also, honokiol was shown to decrease the level of RANTES
(regulated upon activation normal T-cell expressed and secreted)
protein in medium of microglia or astrocytes, which was related to
its effect on microglia NF-κB p65 nuclear translocation28.
2.3. Leukocyte inﬁltration
A growing body of evidence indicates that recruitment of leukocytes
contributes to the initiation and evolution of brain injury after ischemic
stroke. The adhesion and migration of neutrophils is evident in cerebral
venules from several minutes to a few hours following reperfusion. The
population of recruited cells shifts from polymorphonuclear (PMN) to
mononuclear leukocytes and lymphocytes, and leukocyte recruitment
persists for days to weeks following ischemia72,73. Rodents with
reduced PMN or T-lymphocyte accumulation show reduced infarct
volumes and improved neurological outcomes. Prevention of leuko-
cyte–endothelial cell adhesion with adhesion molecule antibodies also
protects against stroke injury74. In a rat MCAO model, leukocyte
adhesion was observed continuously in cerebral microvessels by
infusion of rhodamine 6G, and the number of adherent leukocytes
after I/R increased immediately and remained increased during 60 min
after reperfusion. Pretreatment with TCM preparation Cerebralcare
Granules attenuated this I/R-elicited enhancement of leukocyte
adhesion; the effects of the higher dose (0.8 g/kg) were more
signiﬁcant than those following the lower dose (0.4 g/kg)75. Consis-
tently, Cerebralcare Granules inhibited leukocyte adhesion either
during the early phase (60 min) or in the late phase (5 days) of
reperfusion after global ischemia in gerbils50,51. Using 51Cr-labeled
neutrophil, researchers also demonstrated that tetrandrine decreased
neutrophils recruitment in brain tissue 24 h after reperfusion in rat with
MCAO47. The classic formula Huanglian Jiedu Tang and its consti-
tuents inhibited myeloperoxidase (MPO) activity, an indication of
neutrophil inﬁltration, in ischemic brain tissue by 30% after focal I/R76.
The same result was observed when using other TCM preparations,
such as Shengmai San56, Tongxinluo capsule77, and Chinese materia
medica Zhimu (Rhizoma Anemarrhenae)78, either in rodent global or
focal I/R injury. FBD formula inhibited PMNs inﬁltration in ICR
mouse brain subjected to repetitive 10 min of common carotid arteries
occlusion followed 24 h reperfusion, and in vitro results showed that
FBD formula could inhibit TNF-α-triggered PMNs adhesion to
ECV304 endothelial cells70. In another in vitro experiment, the single
active compound salvianolic acid A was proven to inhibit the
adherence of granulocytes on brain microvascular endothelial cells
(BMEC); the effect was attributed to decreasing the expression of
ICAM-1 on BMEC at the gene and protein levels39.
2.4. Brain blood barrier (BBB) disruption
BBB consists of microvascular endothelial cells, basal lamina,
pericytes and astrocyte endfeet. Microvessel hyperpermeability
disrupts the normal BBB function during cerebral I/R injury.
Microvessel permeability is regulated by both paracellular and
transcellular pathways79. Paracellular pathways are mainly gov-
erned by tight junctions; the loss of tight junction integrity occurs
and directly contributes to cerebral BBB disruption under ischemic
stroke conditions80. An alternative mechanism for BBB openinginvolves upregulation of caveolae, including the expression and
phosphorylation of the structural component caveolin-1 (Cav-1),
as demonstrated by transmission electron microscopy in endothe-
lial cells in several stroke models81. In a rat MCAO model, recent
in vivo studies found that both pre- and post-treatment with the
TCM preparation Cerebralcare Granules reduces FITC-labeled
albumin leakage from cerebral venules evoked by I/R, in either the
early or late phase after reperfusion75,82; the same results were
found in a gerbil global I/R model50,51. Further study using
confocal microscopy revealed that the continuous distributions of
tight junction proteins including claudin-5, occludin, junctional
adhesion molecule-1 (JAM-1) and zonula occludens-1 (ZO-1)
were disrupted after reperfusion for 3 h and 6 days, concomitant
with reduced immune staining. Western blotting indicated the
degradation of tight junction proteins in response to I/R. Interest-
ingly, these losses in structural integrity were reversed by
Cerebralcare Granules treatment. In addition, I/R-induced
increases in the cytoplasmic caveolae of capillary endothelial cells
and cerebral Cav-1 expression were both down-regulated by
Cerebralcare Granules, as observed by electron microscopy and
Western blotting, respectively. Taken together, these ﬁndings
suggest involvement of both the paracellular and transcellular
pathways in the beneﬁcial effects of Cerebralcare Granules on
BBB disruption following cerebral I/R injury82. Similarly, treat-
ment with the TCM preparation Tongxinluo capsule increased
ZO-1 and occludin expression in cerebral microvessels 24 h after
MCAO in mice77. In addition, enzymatic degradation of the
extracellular matrix by matrix metalloproteinases (MMPs), secre-
tion of vascular endothelial growth factor (VEGF), ROS produc-
tion, leukocyte inﬁltration, and inﬂammatory mediator release
within the ischemic core or peri-infarct area have all been
postulated to trigger BBB disruption directly or indirectly during
I/R process. To this end, TCM preparations such as naomaitong
preparation83, and Panax notoginseng saponins combined with
astragaloside15, were reported to protect against cerebral micro-
vessel basement membrane injury via modulating gelatinase
system, inhibiting MMP-2 and MMP-9 expression and improving
tissue inhibitor of metalloproteinase-1 (TIMP-1) protein level in
rodent brain tissue after I/R. Using immunohistochemistry, the
single active component salvianolic acid B was shown to alleviate
the extravasation of immunoglobulin and attenuate MMP-9
expression induced by cerebral I/R, which was related to the
inhibition on p38MAPK activation and extracellular signal-
regulated kinase (ERK) 1/2 phosphorylation41. Other TCM pre-
parations, such as Weinaokang preparation84 and Huatuo Zaizao
extractum85, may also effectively recover BBB ultrastructure
injury induced by I/R via inhibiting expressions of MMP-2 and
MMP-9, which might be associated with reduction of G protein-
coupled receptor kinase 2 (GRK2) in membrane translocation and
activation. Another experiment showed that aromatic resuscitation
drugs have the protection effect on BBB by decreasing the level of
VEGF in addition to MMP-986. Besides, the effects of TCM
preparation, Chinese materia medica and active compounds on
ROS production, leukocyte inﬁltration and inﬂammation all
contribute to ameliorating BBB disruption to some extent, as
discussed above.2.5. Capillary hypoperfusion
It has been known for some time that loss of microvascular
patency impairs cerebral vascular re-perfusion following global or
Ameliorating effects of traditional Chinese medicine preparation 15focal cerebral ischemia87. After reperfusion, adhered leukocytes,
entrapped erythrocytes, and ﬁbrin-platelet deposits obstruct capil-
lary lumens. Moreover, swollen astrocyte endfeet, pericyte con-
traction and microvessel hyperpermeability all contribute to
capillary occlusion after reperfusion88,89. A recent clinical study
showed that perfusion status, rather than successful recanalization,
has a signiﬁcant impact on the outcome of stroke patients90,
suggesting that improvement of microcirculatory reperfusion
seems to be a promising strategy in stroke patients after thrombo-
lysis. With the use of the intravital microscopy equipped with a
high-speed video camera in a rat MCAO model, researchers
demonstrated that the number of open capillaries reduced con-
siderably 60 min after reperfusion, and pre-treatment with TCM
preparation Cerebralcare Granules attenuated this alteration75.
In addition, cerebral blood ﬂow (CBF) in cortex decreased 3 h after
I/R, and this reduction remained for 6 days. Cerebralcare Granules
post-treatment after reperfusion attenuated the I/R-evoked decrease
in CBF82. Consistent with the result observed by intravital micro-
scopy and laser Doppler, transmission and scanning electron
microscopy clearly identiﬁed that pre- or post-treatment with
Cerebralcare Granules ameliorated cerebral microvasculature
changes, including narrowed lumen, rough inner surface, swelling
endothelial cells and perivascular astrocyte end feet. The treatment
also restored the decrease in the number of open capillaries 24 h or
6 days after reperfusion75,82. Similar results were found when using
Cerebralcare Granules in global I/R injury50. Assessment of
hemorheology by a full-automatic hemorheolometer revealed that
acupoint-injection of compound Angelica-root injection (Fufang
Danggui injection) downregulated blood viscosity including high,
medium and low shearing rates, erythrocyte aggregation index, and
rigidity index; deformity index was up-regulated, facilitating cerebral
blood circulation91. Other TCM preparations, such as Erigeron
injection (Dengzhanhuasu injection)92, Astragalus injection (Huangqi
injection)93, Naosaitong preparation94, and icariin combined with
P. notoginseng saponins29 were also reported to improve blood
rheology and CBF after cerebral I/R injury. In addition, Gualou Guizhi
decoction reduced cerebral ischemic spasticity, improved the screen test
and Hoffman's reﬂex scores, which might be related to modulation of
glutamate (Glu) levels and α-amino3-hydroxy-5-methyl-4-isoxazole-
propionic acid (AMPA) receptor expression95.3. Effects of TCM on brain injury and neuron damage
induced by I/R
Within a few minutes of the onset of cerebral ischemia in stroke
patients, the core of brain tissue exposed to the most dramatic
blood ﬂow reduction is mortally injured, and subsequently under-
goes necrotic cell death. The reduction of oxygen and nutrient
supply induces a series of metabolic dysfunctions such as
reduction in ATP formation and energy failure, loss of cell ion
homeostasis, acidosis, membrane depolarization, Ca2þ inﬂux,
excessive release of excitatory amino acids, free radical-mediated
toxicity, all resulting in brain and neuron necrosis96,97. Thrombo-
lysis strategies have proven to be the most effective therapies for
stroke treatment. However, early reperfusion of ischemic brain
tissue can result in harmful consequences, including ROS outburst,
overproduction of inﬂammatory mediators, leukocyte inﬁltration,
microvessel hyperpermeabilty, all of which lead to BBB disruption
and capillary hypoperfusion. Ultimately, activation of these
cascades culminate in cerebral edema and/or brain hemorrhage
and exacerbate brain injury3. On the other hand, cerebralmicrocirculatory disturbances, together with other neurotoxicity
mediators such as Naþ, Ca2þ and Glu, are detrimental to neuronal
survival in the ischemic penumbra or peri-infarct zone; apoptotic
neuron death is a common outcome98.3.1. Effects of TCM on brain injury induced by I/R
As discussed above, TCM has multiple beneﬁcial roles in cerebral
I/R-induced microcirculatory disturbances. Among these are
positive effects on brain injury, such as brain infarction, peri-
vascular edema and hemorrhage after I/R. In this aspect, HE
staining demonstrated a histopathological damage after global or
focal cerebral I/R, which could be inhibited by some TCM
preparations, such as Shengmai San56, Naomaitong preparation99
and active component baicalin19,20. By virtue of magnetic reso-
nance imaging (MRI), rat brain edema was observed 3 h after
MCAO and remained unchanged 6 days after reperfusion. Inter-
estingly, TCM preparation Cerebralcare Granules reduced cere-
bral edema even when administered after the initiation of edema82.
Likewise, scanning electron microscopy revealed swollen glia and
edema around cerebral microvessels which were abrogated by
Cerebralcare Granules50,82 and the active component apigenin18,
after global or focal I/R injury. By means of high performance
liquid chromatography (HPLC) and atomic absorption spectro-
photometry, the TCM preparation Shenfu injection was found to
decrease glutamate and Ca2þ in brain tissue and reduce excitatory
amino acid toxicity, effects which can alleviate tissue edema100.
Using Evan's blue dye extravasation and/or brain water content
assessment, large doses of TCM preparation, Chinese materia
medica, and active compounds were demonstrated to restrain BBB
disruption and brain tissue edema after I/R, although the mechan-
isms for the effects of each TCM may differ. For example,
combinations of total alkaloids from Gouteng (Ramulus Uncariae
cum Uncis) and Xiatianwu (Rhizoma Corydalis Decumbentis)101
and the active compound sodium tanshinone B45 were thought to
act through anti-oxidation, whereas the TCM preparation Naomai-
tong preparation68 and Guizhi Fuling capsules67 may produce
beneﬁcial effects by anti-inﬂammatory mechanisms. In contrast,
FBD formula70 and Chinese materia medica Zhimu (Rhizoma
Anemarrhenae)78 may act through inhibition of leukocyte inﬁltra-
tion, whereas the TCM preparation Shexiang Xingnaoning pre-
paration102 as suggested may act by anti-thrombotic mechanisms.
Finally, Cerebralcare Granules82 and Tongxinluo capsule77 are
thought to maintain the BBB. Consistent with anti-edema effects,
the beneﬁcial effects of TCM preparations, Chinese materia
medica and active compounds on cerebral infarction after I/R
injury have also been reported. For example, 2,3,5-triphenyltetra-
zolium chloride (TTC) staining showed that the TCM preparation
Xuezhikang capsule103, total ﬂavones of Chinese materia medica
Huangshukui (Abelmoschus manihot)104, and active compounds,
such as calycosin24 and astrogaloside16, inhibited brain infarction
mainly by anti-oxidative effect. On the other hand, the classical
formula Buyang Huanwu Tang105, and TCM preparations, such as
Danhong injection106, Astragalus injection (Huangqi injection)93,
and Naosaitong preparation94 were shown to inhibit cerebral tissue
necrosis via promoting blood vessel repair105, anticoagulant and
antiﬁbrinolytic activity106, and improvement of capillary perfu-
sion. In contrast studies on edema and infarction, few studies have
been published showing the ameliorating effect of TCM prepara-
tions, Chinese materia medica, and active compounds on cerebral
hemorrhage induced by I/R injury. However, these medicinals can
Figure 1 Schematic summary of how the TCM preparation, Chinese
materia medica and active compounds ameliorate I/R-induced cerebral
microcirculatory disturbances, brain injury and neuron damage. TCM
preparation, Chinese materia medica and active compounds inhibit
I/R-induced multiple insults in cerebral microcirculation, including
ROS outburst, inﬂammatory mediators overproduction, leukocyte
inﬁltration, microvessel hyperpermeabilty, platelet aggregation, etc.,
leading to BBB disruption and capillary hypoperfusion, which
culminate in ameliorating cerebral edema and/or brain hemorrhage,
and brain injury. On the other hand, by improving cerebral micro-
circulation, together with anti-apoptosis, anti-excitoxicity and pro-
neurogenesis effects, TCM preparation, Chinese materia medica and
active compounds have potential to alleviate neurological deﬁcits after
I/R. BBB, blood brain barrier; EC, endothelial cell; H2O2, hydrogen
peroxide; I/R, ischemia/reperfusion; MMPs, matrix metalloprotei-
nases; NADPH, nicotinamide adenine dinucleotide phosphate; O2
 ,
superoxide anion; OH , hydroxyl radicals; ONOO, peroxynitrite
anion; ROS, reactive oxygen species, TCM, traditional Chinese
medicine; XO, xanthine oxidase; ? denotes inhibition.
Kai Sun et al.16alleviate intracerebral hemorrhage in some situations, such as
surgery107, traumatic intracranial hematoma108, and artiﬁcial
cerebral hemorrhage in animal models109.
3.2. Effects of TCM on neuron damage induced by I/R
A variety of tests are available for evaluation of neurobehavioral
function, such as Long's test33,43,93, Morris water maze
test17,19,110–112, eight-arm radical maze test29,113, step down and
step through test40,53, beam-walking test42, forced swimming test
and tail suspension test103. Using these tests, many TCM prepara-
tions, Chinese materia medica and active compounds have been
shown to alleviate neurological deﬁcits and improve learning and
memory after I/R injury. These include TCM preparations such as
Xiaoxuming decoction112 and Yizhi capsule110,111, and Chinese
materia medica such as Sanqi (Radix et Rhizoma Notoginseng)113,
and Gegen (Radix puerariae) ethanol extract114. The list also
includes active compounds, such as astrogaloside17, salvialonic
acid A40, salvianolic acid B42, morroniside33 and scutellarin43. The
underlying mechanism for neuroprotection in each case is distinct.
Candidate mechanisms include anti-apoptosis, anti-excitoxicity
and pro-neurogenesis. The following sections will discuss each
of these separately.
3.2.1. Effects of TCM on apoptosis
Nissl staining and DNA fragmentation assays demonstrated that the
TCM preparation Naoshuantong capsule reduced neuronal apoptosis
in ischemic cortex and in the hippocampal CA1 region after rat
MCAO; neurological functional deﬁcits were also attenuated.
Naoshuantong capsule also suppressed the overexpression of Bax
and activation of caspases-3, -8 and -9, inhibited the reduction of
Bcl-2 expression and depressed the Bax/Bcl-2 ratio115. Likewise,
Nissl and terminal-deoxynucleoitidyl transferase mediated nick end
labeling (TUNEL) staining, along with electron microscopic obser-
vations, showed that the TCM preparation Cerebralcare Granules
attenuated neuron death in cortex after focal I/R and in hippocampal
CA1 region after global I/R. These beneﬁcial effects were partly
attributed to improving cerebral microcirculatory disturbances,
balancing Bcl-2 superfamily protein expression, and modulation
of the PUMA-p53 proapoptotic pathway51,75. Staining with hema-
toxylin and eosin (HE), TUNEL and Hoechst 33258 was used to
show that the classical formula Dihuang Yinzi116, the TCM
preparation Astragalus injection (Huangqi injection)93, and active
compounds, such as astragalosides17 and tetrahydroxystilbene
glucoside46 attenuated neuronal apoptosis. Mechanisms for these
actions include ERK activation, inhibition of JNK phosphorylation,
and up-regulation of Akt phosphorylation; this last mechanism may
also be important in the neuroprotective effect of eupatilin25 and
resveratrol37. Other active compounds, such as Leonurine30 and
ginsenoside Re26 were reported to attenuate I/R-induced mitochon-
drial swelling, reverse changes in mitochondrial membrane poten-
tial, and restore cytochrome c levels in mitochondria. The anti-
apoptotic actions of these preparations were suggested to contribute
to these effects. Another experiment found that the active compound
scutellarin alleviated mitochondrial dysfunction through inhibition
of poly-ADP-ribose polymerase (PARP) overactivation and the
subsequent translocation of apoptosis inducing factor (AIF) from
mitochondria to nuclei following cerebral I/R43. Other TCM
preparations, such as Buyang Huanwu decoction117, Xingnaojing
plus Xuesaitong injection118, Naoshuantong capsule119, Yinxing
(Folium Ginkgo) extract120, and active compounds, such asginsenoside Rg327 and lycopene32 displayed similar neuroprotective
actions via anti-apoptotic effects.
3.2.2. Effects of TCM on excitoxicity
Excitatory amino acids accumulate in the extracellular space
following ischemia and activate their receptors, leading to intra-
cellular Ca2þ overload followed by neuronal damage. HPLC
results demonstrated that the classical formula Buyang Huanwu
decoction121, Tianma Gouteng Fang122, and Chinese materia
medica Yinxing (Folium Ginkgo) extract123 decreased brain levels
of the excitatory amino acids Glu and aspartate (Asp), and
increased levels of the inhibitory amino acids γ-aminobutyric acid
(GABA), taurine and glycine (Gly). Such a pattern seems to
maintain the balance of inhibitory and excitatory amino acids in
brain after I/R injury. TCM preparations, Chinese materia medica
and active compounds have also been reported to inﬂuence the
excitatory amino acid receptors. For example, TCM preparations
such as Huanshaodan decoction124 and Tianma Cuzhi granules125
were found to reduce the N-methyl-D-aspartic acid (NMDA)
receptor activity in both cerebral cortex and hippocampus. Single
active components, such as sodium tanshione B45 and senegenin44
decreased NMDA receptor protein expression and mRNA levels of
its NR2B subunit in hippocampus. The classical formula Buyang
Huanwu decoction126 decreased neurological deﬁcit scores via
down-regulating AMPA receptors, glutamate receptor-1 RNA and
glutamate receptor-2 protein expression. In primary hippocampal
neuron cultures, an active component ﬂavonoid extract from
Table 3 Effect of TCM preparation, Chinese materia medica and active compounds on pathogenesis of cerebral microcirculatory
disturbances induced by I/R.
Effect Target TCM Refs.
Amelioration of oxidative stress ROS source Cerebralcare Granules 50,51
Yiqi Tongluo Jiedu capsule 52
Chishao total glycoside 53
Danshen 54
Astragaloside 13,14
Baicalin 19
Notoginsenoside R1 34
Tetrahydroxystilbene glucoside 46
Free-radical scavenger Chaihu Jia Longgu Muli Tang 55
Guizhi Fuling Wan 55
Huanglian Jiedu Tang 55
Salvianolic acid A 38
Anti-oxidase activity Shengmai San 56–58
Tongxinluo capsule 62
Baihuasuantenggou extract 59,60
Lavender oil 61
Yimucao injection 63
Yinxing extract 64
30-Methoxy-puerarin 12
Paeonol 35
Amelioration of inﬂammation Cytokines/chemokines FBD formula 71
Guizhi Fuling capsule 67
Naomaitong preparation 68
Taohong Siwu Tang 69
Danshen 71
Honokiol 28
Tetrandrine 47
Adhesion molecules Naomaitong preparation 68
Tetrandrine 47
Other mediators (TGF-β1, iNOS, Cox-2) Taohong Siwu Tang 69
Danshen 71
Honokiol 28
Resveratrol 36
Amelioration of leukocyte inﬁltration Leukocyte-endothelial interaction Cerebralcare Granules 50,51,75
FBD formula 70
Salvianolic acid A 39
Tetrandrine 47
MPO increase Huanglian Jiedu Tang 76
Shengmai San 56
Tongxinluo capsule 77
Zhimu 78
Amelioration of BBB disruption Endothelial cell junction Tongxinluo capsule 77
Cerebralcare Granules 82
MMP/TIMP balance Huatuo Zaizao extractum 85
Naomaitong preparation 83
Weinaokang preparation 84
Aromatic resuscitation drugs 86
Panax notoginseng saponins plus astragaloside 15
Salvianolic acid B 41
Amelioration of capillary hypoperfusion CBF Naosaitong preparation 94
Cerebralcare Granules 50,75,82
Astragalus injection 93
Erigeron injection 92
Hemorheology Compond Angelica-root injection 91
Icariin plus Panax notoginseng saponins 29
Cerebral spasticity Gualou Guizhi decoctiom 95
Ameliorating effects of traditional Chinese medicine preparation 17
Table 4 Effect of TCM preparation, Chinese materia medica and active compounds on brain injury induced by I/R.
Effect Mechanism TCM Refs.
Amelioration of brain edema Inhibiting excitoxicity Shenfu injection 100
Anti-oxidation Shengmai San 56
Cerebralcare Granules 50
Gouteng total alkaloids 101
Xiatianwu total alkaloids 101
Sodium tanshinone B 45
Anti-inﬂammation Guizhi Fuling capsules 67
Naomaitong preparation 68
Shengmai San 56
Baicalin 20
Inhibiting leukocyte inﬁltration FBD formula 70
Cerebralcare Granules 50,75
Zhimu 78
Anti-thrombosis Shexiang Xingnaoning preparation 102
Maintaining BBB Tongxinluo capsule 77
Cerebralcare Granules 82
Amelioration of brain infarction Anti-oxidation Xuezhikang capsule 103
Huangshukui total ﬂavones 104
Astragaloside 16
Calycosin 24
Anti-thrombosis Danhong injection 106
Improve capillary perfusion Naosaitong preparation 94
Astragalus injection 93
Promote blood vessel repair Buyang Huanwu Tang 105
Table 5 Effect of TCM preparation, Chinese materia medica and active compounds on neuron damage induced by I/R.
Effect Mechanism TCM Refs.
Anti-neuronal apoptosis Down-regulating caspases Buyang Huanwu Tang 117
Ginsenoside Rg3 27
Morroniside 33
To balance Bcl-2/Bax Naoshuantong capsule 115
Xiaoxuming decoction 112
Cerebralcare Granules 51
Lycopene 32
Restoring mitochondrial membrane potential Leonurine 30
Ginsenoside Re 26
Regulating p53-PUMA pathway Cerebralcare Granules 75
Regulating MAPK/Akt pathway Dihuang Yinzi 116
Astragalus injection 93
Astragaloside 17
Eupatilin 25
Resveratrol 37
Tetrahydroxystilbene glucoside 46
Regulating PARP-AIF pathway Scutellarin 43
Anti-neurotoxicity Decreasing excitoxicity amino acids Buyang Huanwu Tang 121
Tianma Gouteng Fang 122
Gegen ethonal extract 114
Yinxing extract 120,123
Decreasing excitoxicity amino acid receptor Buyang Huanwu Tang 126
Huanshaodan decoction 124
Tianma Cuozhi granules 125
Shishu leaves ﬂavonoids extract 127
Yinxing extract 128
Senegenin 44
Sodium tanshinone B 45
Decreasing [Ca2þ]i Shenqi Fuzheng injection
129
Yinxing extract 123
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Table 5 (continued )
Effect Mechanism TCM Refs.
Neurogenesis Promoting NSC proliferation Tongxinluo capsule 133,134
Panax notoginseng saponins 136
Increasing neurotrophic factors (VEGF, BNDF, bFGF, NGF) Naoluo Xintong recipe 135
Sanqi 113
Astragaloside 13
Baicalin 21,22
Promoting neuronal self-repair Weinaokang preparation 137
Salvianolic acid B 42
Amelioration of microcirculatory
disturbances
Anti-oxidation Huanglian Jiedu Tang 138
Xingnaojing plus Xuesaitong injection 118
Breviscapine injection 139
Chishao total glycoside 80
Yinxing extract 120
Icariin plus Panax notoginseng saponins 29
Luteolin 31
Lycopene 32
Salvianolic acid A 40
Anti-inﬂammation Shexiang Xingnaonin preparation 102
Yinxing extract 120
Apigenin 18
Baicalin 19,23
Lycopene 32
Promoting capillary perfusion Cerebralcare Granules 51,75
Ameliorating effects of traditional Chinese medicine preparation 19Shishu (Diospyros kaki) leaves127 and Yinxing (Folium Ginkgo)
extract128 protected neurons from Glu- or NMDA receptor-induced
excitotoxicity. Also, microﬂuorometry showed that the Chinese
materia medica Yinxing (Folium Ginkgo) extract decreased
intracellular Ca2þ concentrations in primary cultured hippocampal
neurons treated with Glu123. In addition, injections of the TCM
preparation Shenqi Fuzheng improved neuronal deﬁcits, an effect
which was suggested to be related to inhibition of Ca2þ aggrega-
tion in brain129.3.2.3. Effects of TCM on neurogenesis
Given that the proliferation of endogenous neuron stem cells and
neurogenesis occurs in rodents130, as well as in primate131 and
patients132 after ischemic stroke, pharmacological interventions
related to neurogenesis are believed to be a key strategy to
improve the neuron functions after cerebral I/R injury. TCM ﬁnds
its role in this ﬁeld as well. It was reported that the TCM
preparation Tongxinluo capsule increased the number of nestin-
positive neurons and VEGF mRNA expression in the rat subven-
tricular zone and hippocampal subdentate gyrus zone of the
ischemic hemisphere after MCAO, indicating a capacity of
promoting differentiation and proliferation of the neural stem
cells133,134. In addition to VEGF, brain-derived neurotrophic factor
(BNDF)21,22,113, basic ﬁbroblast growth factor (bFGF)135 and
nerve growth factor (NGF)13 may also be targets for the pro-
neurogenic potential of some TCM preparations (e.g., Naoluo
Xintong recipe135), Chinese materia medica (e.g., Sanqi (Radix et
Rhizoma Notoginseng)113), and active components (baicalin21,22
and astragaloside13). In an in vitro study, P. notoginseng saponins,
active components extract from Sanqi (Radix et Rhizoma Noto-
ginseng), was shown to promote rat hippocampal neural stem cells(NSC) proliferation and the expression of nestin/BrdU. mRNA
levels of class III β-tublin (Tuj-1), vimentin, and nestin were also
enhanced. Also, P. notoginseng saponins increased area density,
optical density and numbers of nestin/BrdU, nestin/vimentin, and
nestin/Tuj-1 positive NSC following OGD136. The TCM prepara-
tion Weinaokang preparation137 and the single active component
salvianolic acid B42, among others, were reported to improve
neurogenesis and to promote the repair of ischemic areas.3.2.4. Other neuroprotective mechanisms of TCM preparation,
Chinese materia medica and active compounds
In addition to aforementioned mechanisms, TCM preparations,
Chinese materia medica and active compounds are known to
alleviate neuron damage after cerebral I/R indirectly via anti-
oxidant, anti-inﬂammatory roles and promotion of capillary
perfusion around neurons. For example, the classical formula
oren-gedoku-to (Huanglian Jiedu Tang) lowered neuronal death by
increasing the expression of Cu/Zn-SOD in the hippocampus of
ischemic mice138. The TCM preparation Breviscapine injection
(Dengzhanhuasu injection)139, and active compounds, such as total
glycoside from Chishao (Radix Paeoniae Rubra)53 and luteolin31,
ameliorated neurological deﬁcit and improved neuronal function
through anti-oxidant actions as well. In addition, electron micro-
scopic studies found that TCM preparations, such as Cerebralcare
Granules51,75, Shexiang Xingnaonin preparation102 and the single
active compound apigenin18, exhibited a potential to decrease
neurological scores and improve pathomorphology and neuron
ultrastructure of ischemic cortex and hippocampal CA1 region
after I/R. Suggested mechanisms for these effects include inhibition of
cytokine production and platelet aggregation102, or promotion of
capillary opening51,75. Similarly, HE staining was used to show that
Kai Sun et al.20the active compound baicalin increased neurons with pycnotic shape
and condensed nuclei in cortex and hippocampus, effects which were
related to suppression of NF-κB p65 activation23.4. Summary
The present paper provides an overview of the ameliorating effects
of compound TCM preparations, Chinese materia medica and
active components on I/R-induced cerebral microcirculatory dis-
turbances, brain injury and neuron damage, as summarized in
Fig. 1.(1) Many studies demonstrated that compound TCM prepara-
tions, Chinese materia medica and their active components
can ameliorate I/R-induced cerebral microcirculatory distur-
bances, including enhanced ROS production, release of
cytokines/chemokines/adhesion molecules, leukocyte recruit-
ment, microvessel hyperpermeability, BBB disruption and
capillary hypoperfusion (Table 3).(2) Compound TCM preparations, Chinese materia medica and
their active components are capable of ameliorating I/R-
induced brain injury, such as brain infarction and perivas-
cular edema. Such effects are attributable to beneﬁcial
actions on cerebral microcirculatory disturbances, together
with attenuation of excitoxicity (Table 4).(3) Compound TCM preparations, Chinese materia medica and
their active components have the potential to alleviate
neurological deﬁcits and improve learning and memory
capacity after I/R injury. Underlying mechanisms for
these effects include inhibition of apoptosis, excitoxicity,
oxidation and inﬂammation, along with stimulation of pro-
neurogenesis (Table 5).(4) In spite of a number of clinical studies illustrating the
ameliorating effects of TCM preparations, Chinese materia
medica and active compounds on cerebral I/R-related dis-
eases, strictly randomized, double-blind, placebo-controlled,
and multicenter clinical trials remain to be conducted with
large samples. More evidence-based data are required to
conﬁrm the effects of TCM preparation, Chinese materia
medica and active compounds, especially Chinese classic
formulas, on ischemic stroke in clinical studies.(5) Majority of the studies concerning the protective effects of
TCM preparation, Chinese materia medica and active com-
pounds on I/R-induced cerebral injury and neuron damage
focus on ROS production, cytokine release, leukocyte
recruitment and microvessel hyperpermeability. More atten-
tion should be paid to other microcirculatory insults, includ-
ing platelet aggregation, mast cell degranulation, thrombus
formation and lymphocyte activation. Furthermore, future
studies should place more emphasis on mechanistic explora-
tion in depth rather than merely descriptive observation.
For instance, what is the relationship between brain
injury (especially cerebral microcirculatory disturbances)
and delayed neuron damage? What are the initiating
effector/receptor and speciﬁc signaling molecules for TCM
preparations, Chinese materia medica and active compounds
to regulate inﬂammatory responses, such as ROS production,
cytokine release and leukocyte activation? Moreover, addi-
tional mechanisms that participate in ischemic brain injury
and neuron damage should be addressed further in studying
the role of TCM preparation, Chinese materia medica andactive compounds in cerebral I/R injury. These energize
metabolism, microglia activation, aquaporin molecules, and
cyclic adenosine monophosphate (cAMP).Ischemic stroke, post I/R-induced cerebral microcirculatory
disturbances, subsequent brain injury, and neuron damage are
complicated processes, and require interventions at multiple targets
for successful treatment. TCM preparations and Chinese materia
medica contain multiple active ingredients which been widely used
for decades in the clinic as a potential therapeutic strategy for I/R-
related cerebral diseases. Further clinical and experimental
research is needed to understand their actions.References
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